Inari Medical Insider Sold Shares Worth $2,002,000, According to a Recent SEC Filing
Truist Financial Maintains Inari Medical(NARI.US) With Hold Rating, Maintains Target Price $50
A Quick Look at Today's Ratings for Inari Medical(NARI.US), With a Forecast Between $50 to $74
Inari Medical PEERLESS Results Show Superiority Of FlowTriever Compared To Catheter-Directed Thrombolytics For Intermediate-Risk Pulmonary Embolism, Published In 'Circulation'; PEERLESS Met Its Primary Composite Endpoint
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
Inari Medical Up Over 15%, On Track for Largest Percent Increase Since August 2023 -- Data Talk
